A brand new examine demonstrates {that a} transportable electrochemical sensing know-how often called eRapid may very well be a great instrument to allow the cheap, multiplexed detection of various SARS-CoV-2-directed antibodies on the point-of-care. Researchers confirmed that particularly engineered eRapid sensors can detect antibodies concentrating on the virus’ so-called nucleocapsid (N) protein from ultra-small samples of blood plasma and dried blood spots with 100% sensitivity and specificity inside lower than 10 minutes.